Results 101 to 110 of about 4,977 (213)

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma [PDF]

, 2017
Background: Tiotropium is a long acting antimuscarinic (LAMA), licenced as triple therapy with inhaled corticosteroid and long acting beta-agonist (ICS/LABA).
American Thoracic, Attanasi, Aziz, Aziz, Battram, Boterman, Britton, Costa, Currie, Currie, Fardon, Fryer, Gosens, Grove, Juniper, Juniper, Kerstjens, Kerstjens, Kistemaker, Koskela, Lipworth, Lipworth, Lipworth, Lipworth, Lipworth, Manoharan, Miller, Moulton, Nair, Naline, Newnham, Newnham, O'Connor, Pera, Peters, Porsbjerg, Santanello, Short, Short, Tan, Vogelmeier, Wood   +41 more
core   +2 more sources

Efficacy and safety of carvedilol in combination with bronchodilators in patients with CHF of ischemic origin and COPD.

Клиническая практика, 2019
Objective. To study the effectiveness of carvedilol, tiotropium bromide and indacaterol in complex therapy on clinical and functional parameters in patients with CHF of ischemic origin in combination with COPD. Material and methods. The study included
Vladimir V. Evdokimov, A. G. Evdokimova, E. N. Yushchuk   +2 more
doaj   +1 more source

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS.   +12 more
europepmc   +1 more source

New targets for resolution of airway remodeling in obstructive lung diseases. [PDF]

, 2018
Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD).
Deshpande, Deepak A., Nayak, Ajay P., Penn, Raymond B   +2 more
core   +2 more sources

Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. [PDF]

J Manag Care Spec Pharm, 2023
Sethi S, Palli SR, Bengtson LGS, Buysman EK, Clark B, Sargent A, Shaikh A, Ferguson GT.   +7 more
europepmc   +1 more source

1H-NMR-based metabolic profiling of healthy individuals and high-resolution CT-classified phenotypes of COPD with treatment of tiotropium bromide

International Journal of COPD, 2018
Li-Chuan Tan,1 Wen-Jie Yang,2 Wei-Ping Fu,1 Ping Su,2 Jing-Kui Shu,1 Lu-Ming Dai1 1Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, People’s Republic of China ...
Tan LC, Yang WJ, Fu WP, Su P, Shu JK, Dai LM   +5 more
doaj  

Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease. [PDF]

Comput Math Methods Med, 2021
Yu S, Zhang C, Yan Z, Fang Q, Gao X.
europepmc   +1 more source

Efficacy of tiotropium in the prevention of exacerbations of COPD

Therapeutic Advances in Respiratory Disease, 2009
Exacerbations are the most frequent cause of medical visits, hospital admissions and death among patients with chronic obstructive pulmonary disease (COPD).
Antonio Anzueto, Marc Miravitlles
doaj   +1 more source

Influencing the Decline of Lung Function in COPD: Use of Pharmacotherapy [PDF]

, 2013
Chronic obstructive pulmonary disease (COPD) is a common and deadly disease. One of the hallmarks of COPD is an accelerated decline in lung function, as measured by spirometry.
Gladysheva, Ekaterina S., Malhotra, Atul, Owens, Robert Llewellyn   +2 more
core  

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Sethi S, Clark B, Bengtson LGS, Buysman EK, Palli S, Sargent A, Shaikh A, Ferguson GT.   +7 more
europepmc   +1 more source